EARLY ASSESSMENT OF MINIMAL RESIDUAL DISEASE (MRD) BY OPTIMIZED REAL-TIME QUANTITATIVE PCR (RQ-PCR) ASSAY FOR DETECTION OF WT1 TRANSCRIPTS PROVIDES AN INDEPENDENT PREDICTOR OF DISEASE RELAPSE IN ACUTE MYELOID LEUKEMIA: A EUROPEAN LEUKEMIANET (ELN) STUDY

被引：0

作者：

Cilloni, D. ^{[1
]}

Renneville, A. ^{[2
]}

Hermitte, F. ^{[3
]}

Hills, R. K. ^{[4
]}

Daly, S. ^{[5
]}

Jovanovic, J. ^{[6
]}

Gottardi, E.

Fava, M. ^{[1
]}

Schnittger, S. ^{[7
]}

Weiss, T. ^{[7
]}

Izzo, B. ^{[8
]}

Nomdedeu, J. ^{[9
]}

van der Heijden, A. ^{[10
]}

van der Reijden, B. ^{[10
]}

van der Velden, V. ^{[11
]}

Rohon, P. ^{[12
]}

Ommen, H. ^{[13
]}

Polak, J. ^{[14
]}

Jansen, J. ^{[10
]}

Preudhomme, C. ^{[2
]}

Saglio, G. ^{[1
]}

Grimwade, D. ^{[6
]}

机构：

[1] Univ Turin, Turin, Italy

[2] Hop Calmette, Dept Hematol, Lille, France

[3] R&D Ipsogen, Marseille, France

[4] Univ Wales Coll Cardiff, Dept Haematol, Cardiff CF1 3NS, S Glam, Wales

[5] Mission Res Inc, Dept Hematol, Manchester, Lancs, England

[6] Dept Genet KCL, London, England

[7] Molec Diag MLL, Munich, Germany

[8] Univ Naples Federico II, Dept Hematol, Naples, Italy

[9] Hosp Santa Creu & Sant Pau, Dept Hematol, Barcelona, Spain

[10] Radboud Univ Nijmegen Med Ctr, Dept Hematol, Nijmegen, Netherlands

[11] Erasmus MC, Dept Immunol, Rotterdam, Netherlands

[12] Fac Hosp, Dept Hematol, Olomouc, Czech Republic

[13] Dept Hematol Amtssygehus, Aarhus, Denmark

[14] DNA Diag Inst Hematol, Prague, Czech Republic

来源：

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2008年 / 93卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

0421

引用

页码：169 / 169

页数：1

共 50 条

[1] Real-time quantitative PCR (RQ-PCR) detection of minimal residual disease (MRD) by optimized WT1 assay to enhance risk stratification in acute myeloid leukemia (AML):: A European leukemia net study.
Cilloni, Daniela
Renneville, A.
Hermitte, F.
Hills, R. K.
Daly, S.
Jovanovic, J.
Gottardi, E.
Fava, M.
Schnittger, S.
Izzo, B.
Nomdedeu, J.
Van der Heijden, A.
Van der Velden, V.
Rohon, P.
Ommen, H.
Polak, J.
Jansen, J.
Preudhomme, C.
Saglio, G.
Grimwade, D.
BLOOD, 2007, 110 (11) : 167A - 167A
[2] Real-Time Quantitative Polymerase Chain Reaction Detection of Minimal Residual Disease by Standardized WT1 Assay to Enhance Risk Stratification in Acute Myeloid Leukemia: A European LeukemiaNet Study
Cilloni, Daniela
Renneville, Aline
Hermitte, Fabienne
Hills, Robert K.
Daly, Sarah
Jovanovic, Jelena V.
Gottardi, Enrico
Fava, Milena
Schnittger, Susanne
Weiss, Tamara
Izzo, Barbara
Nomdedeu, Josep
van der Heijden, Adrian
van der Reijden, Bert A.
Jansen, Joop H.
van der Velden, Vincent H. J.
Ommen, Hans
Preudhomme, Claude
Saglio, Giuseppe
Grimwade, David
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (31) : 5195 - 5201
[3] Quantitative analysis of WT1 gene for detection of minimal residual disease in acute leukemia by real-time RT-PCR
Ghaffari, S. H.
Hemmati, T.
Rostami, S.
Alimoghaddam, K.
Ghavamzadeh, A.
EJC SUPPLEMENTS, 2005, 3 (02): : 285 - 285
[4] Assessment of minimal residual disease (MRD) by qualitative RT-PCR (Q-PCR) vs real-time quantitative RT-PCR (RQ-PCR) in a phase II study of acute promyelocytic leukemia (APL)
Gallagher, RE
Schachter-Tokarz, EL
Jones, DA
Estey, EH
BLOOD, 2005, 106 (11) : 912A - 912A
[5] A new method of Wilms' tumor gene WT1 quantitative assay (WT1 assay) based on real-time PCR for the detection of minimal residual disease (MRD) in patients with leukemia and myelodysplastic syndromes (MDS)
Tamaki, H
Ogawa, H
Oka, Y
Soma, T
Sugiyama, H
LEUKEMIA, 2001, 15 (12) : 2024 - 2024
[6] Real-time PCR for quantitative detection of minimal residual disease (MRD) in childhood acute lymphoblastic leukemia (ALL)
Pongers-Willemse, MJ
Verhagen, OJHM
Tibbe, GJM
Wijkhuijs, JM
De Haas, V
Van Wering, ER
Van der Schoot, CE
Van Dongen, JJM
BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 292 - 292
[7] Real-time quantitative polymerase chain reaction (RQ-PCR) monitoring of minimal residual disease (MRD) in core binding factor acute myeloid leukaemia (CBF AML).
Lane, Steven W.
Saal, Russell
Mollee, Peter
Grigg, Andrew
Taylor, Kerry
Seymour, John Francis
Kennedy, Glen
Williams, Bronwyn
Jones, Mark
Grimmett, Karen
Griffiths, Vanessa
Gill, Devinder
Hourigan, Matthew
Marlton, Paula
BLOOD, 2006, 108 (11) : 651A - 651A
[8] Monitoring of minimal residual disease (MRD) by real-time quantitative reverse transcription PCR (RQ-RT-PCR) in childhood acute myeloid leukemia with AML1/ETO rearrangement
S Viehmann
A Teigler-Schlegel
J Bruch
C Langebrake
D Reinhardt
J Harbott
Leukemia, 2003, 17 : 1130 - 1136
[9] Monitoring of minimal residual disease (MRD) by real-time quantitative reverse transcription PCR (RQ-RT-PCR) in childhood acute myeloid leukemia with AML1/ETO rearrangement
Viehmann, S
Teigler-Schlegel, A
Bruch, J
Langebrake, C
Reinhardt, D
Harbott, J
LEUKEMIA, 2003, 17 (06) : 1130 - 1136
[10] Quantitation of minimal residual disease (MRD) in TEL/AML1 positive patients during treatment by real-time quantitative RT-PCR (RQ-PCR)
Ballerini, P
Landman-Parker, J
Blaise, A
Laurendeau, I
Vidaud, M
Adam, M
Auvrignon, A
Leverger, G
Douay, L
Cayre, YE
Bièche, I
LEUKEMIA, 2001, 15 (12) : 2018 - 2018

← 1 2 3 4 5 →